C

Compugen Ltd
D

CGEN

2.10000
USD
-0.08
(-3.67%)
مغلق
حجم التداول
9,199
الربح لكل سهم
-0
العائد الربحي
-
P/E
70
حجم السوق
188,026,507
نظرة عامةالتوصياتالأفكار والتحليلاتالأخبار
أصول ذات صلة
    AMGN
    AMGN
    5.10
    (1.71%)
    303.15 USD
    BMY
    BMY
    0.050
    (0.09%)
    55.840 USD
    GILD
    GILD
    -0.140
    (-0.13%)
    109.920 USD
    I
    INCY
    0.790
    (1.11%)
    72.150 USD
    MRNA
    MRNA
    1.785
    (5.29%)
    35.535 USD
    NVS
    NVS
    2.100
    (1.96%)
    109.370 USD
    REGN
    REGN
    4.37
    (0.63%)
    700.66 USD
    المزيد
الأخبار
المقالات

العنوان: Compugen Ltd

القطاع: Healthcare
الصناعة: Biotechnology
Compugen Ltd is a clinical-stage therapeutic discovery and development company utilizing its broadly applicable predictive computational discovery capabilities to identify novel drug targets and new biological pathways to develop therapeutics in the field of cancer immunotherapy. Its immuno-oncology pipeline consists of four clinical-stage programs, targeting immune checkpoints the company discovered computationally, COM701, COM902, bapotulimab. The company's therapeutic pipeline of early-stage immuno-oncology programs consists of programs aiming to address various mechanisms of immune resistance, including myeloid targets.